Association between timing of speech and language therapy initiation and outcomes among post-extubation dysphagia patients: a multicenter retrospective cohort study. [PDF]
Hongo T +13 more
europepmc +1 more source
ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos +9 more
wiley +1 more source
Strengths and Challenges of the Speech and Language Therapy (SLT) Degree Apprenticeship Route: Initial Stakeholder Perspectives. [PDF]
Richards H, Lundie V.
europepmc +1 more source
Reflective practice across speech and language therapy and education: a protocol for an integrative review. [PDF]
McCluskey J, Gallagher AL, Murphy CA.
europepmc +1 more source
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi +5 more
wiley +1 more source
Speech and Language Therapy Weekend Service in Inpatient Rehabilitation: A Qualitative Study Exploring Perspectives of People With Stroke. [PDF]
Davies L, Lanyon L, O'Halloran R.
europepmc +1 more source
Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS
ABSTRACT Objective Corticospinal tract damage is common in people with MS, but the degree of clinical symptoms varies. We hypothesize that corticospinal tract lesions are more extensive and severe in people with MS with motor impairments in both upper and lower limbs.
Mathilde Liffran +13 more
wiley +1 more source
Digital tool as speech and language therapy for patients with post-stroke aphasia. [PDF]
Ruiz Ares G +11 more
europepmc +1 more source
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou +15 more
wiley +1 more source

